Entity

Time filter

Source Type


Grant
Agency: Cordis | Branch: FP7 | Program: CP | Phase: ICT-2011.3.6 | Award Amount: 11.87M | Year: 2011

X10D aims to enable organic photovoltaics (OPV) to enter the competitive thin-film PV market. It will achieve this by pooling the knowledge and expertise of the leading research institutes and start-up companies in Europe, and is the first project of its kind to leverage this knowledge irrespective of the processing technology. It will use the strengths available in device efficiency and architectures in both solution processed as well as small molecule based OPV.
The objective for X10D is to develop efficient, low-cost, stable tandem organic solar cells by applying new designs, materials and manufacturing technologies to create market-competitive OPV modules. Therefore, X10D proposes to bring together partners that compose a complete and unique OPV research and development consortium, from academic partners, research centers, SMEs, and large companies. Together, the X10D partners cover each segment of the complete value chain: materials development and up scaling, device development and up scaling, large area deposition equipment and processes, novel transparent conductors, laser scribing equipment and processes, encapsulation technologies, energy, life-cycle, and cost analysis and finally end-users.
The main objectives for X10D can be quantified more explicitly as:- To increase the power conversion efficiency to achieve at least a 12% on cell level (1cm), and 9% on module level (100 cm)- To guarantee a minimum of 20 years life for OPV modules on glass, and 10 years on foil- To decrease the cost under 0.70 /Watt-peak


J-AGE, the Coordination Action for the early implementation of the Joint Programming Initiative (JPI) More Years Better Lives the Challenges and Opportunities of Demographic Change, will support and foster the overall management of the JPI, the development of the Strategic Research Agenda and its implementation through joint activities between Member States, the mapping of relevant national programmes and a complementary foresight activity. Furthermore, the work plan will include dissemination and information exchange with scientific and societal stakeholders, policy makers and research funders as well as an evaluation and monitoring exercise. Ultimately, the project and the JPI seek to strengthen the base of multi-disciplinary and holistic ageing research in Europe and to provide scientific evidence for policy responses to demographic change.


J-AGEII, the Coordination Action for implementation and alignment activities of the Joint Programming Initiative (JPI) More Years Better Lives the Challenges and Opportunities of Demographic Change, will support and foster the overall management of the JPI, update the Strategic Research Agenda and support implementation through joint activities between Member States. Furthermore, the work plan will include dissemination and information exchange with scientific and societal stakeholders, policy makers and research funders as well as an evaluation and monitoring exercise. Ultimately, the project and the JPI seek to stimulate the alignment of relevant national programmes and EU initiatives, strengthen the base of multi-disciplinary and holistic ageing research in Europe and to provide scientific evidence for policy responses to demographic change.


Grant
Agency: Cordis | Branch: H2020 | Program: CSA | Phase: INSO-7-2014 | Award Amount: 3.20M | Year: 2015

Building on the ERA-LEARN, NETWATCH & JPIs To Co Work predecessor projects ERA-LEARN 2020 will provide an integrated framework to make P2P more efficient and effective and support national and regional funding organisations in the preparation, implementation and monitoring of joint actions. ERA-LEARN 2020 will increase mutual learning within the P2P community and will thereby support the implementation of streamlined mechanisms. Useful input will be provided towards the analysis and possible future development of P2P formats. ERA-LEARN 2020 will highlight synergies between different forms of national/regional programme coordination and facilitate high-level analysis of P2P policy-related issues. It will provide tools for analysis and communication formats for supporting future developments of transnational programme coordination. The ERA-LEARN 2020 team is highly qualified & complementary with national authorities and experts for analysis with many years experience of P2P at both the operational and policy levels. ERA-LEARN 2020 will: 1. provide a web-based information, learning and support platform for P2P to avoid duplication of efforts; 2. support the ongoing optimisation of P2P networks by providing a toolbox for the wider activities of joint programming, particularly the JPIs, Art.185 and ERA-NET Cofund instrument, as well as their associated impacts; 3. implement a systematic process for monitoring & impact assessment of P2P networks, including their impacts at both the policy, programme and co-funded RTD project-level; 4. assess and benchmark current approaches to alignment and explore options for new modalities to better align national and/or regional activities under common research agendas; 5. implement an annual cycle of knowledge exchange aimed at increasing the impact of investment in P2P activities and exploring options to support less research intensive countries.


Grant
Agency: Cordis | Branch: H2020 | Program: CSA | Phase: NMP-09-2014 | Award Amount: 2.00M | Year: 2015

ENATRANS main objective is to network and support SMEs in translation of nanomedicine in Europe by providing a one-stop-shop service to interact and share information, experience and advice with up-to-date information and interactive tools, but also enabling personal contacts. To be successful SMEs need to understand the requirements of the complex ecosystem made up of regulatory and reimbursement agencies, as well as the requirements of large industrial companies and clinical needs. ENATRANS will gather and provide information about approval processes, regulatory authorities and agencies, clinical and market data, and specific nanomedicine value chain analysis, relevant SME support projects and organisations. ENATRANS will convert this critical information in dedicated learning programs and tools dedicated to translation of nanomedicine. ENATRANS aims at implementing the concept of a Translation Advisory Board (TAB) as central element of the ETPN White Paper. A TAB will be set-up with senior experienced translation experts to guide R&D teams (in SMEs and research institutes) along the translation process to successfully make it to clinical trials and later to the market. Promising projects identified and supported by the TAB need access to clinical centers for first studies in patients, which are able to handle the specificity of new nanotechnology based therapeutics. In addition, financial resources are needed to go pass the regulatory and scale-up processes, which often require funding from investors and/or large companies. ENATRANS will build bridges to clinical trial centers, investors and large companies. Promising projects need guidance to successfully master privileged contacts with the medical, the business or the investment community. ENATRANS will deliver special coaching sessions prior to showcasing of promising projects. Partners in ENATRANS are VDI/VDE-IT, Nanobiotix, CEA, bioanalytik-muenster, Tel Aviv University, Fondazione Don Gnocchi, TecMinho.

Discover hidden collaborations